Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
sell

Cardiff Oncology Inc. sell dimontalban

Cardiff Oncology Inc.
Start price
€4.44
19.12.24 / 60%
Target price
€1.00
19.12.25
Performance (%)
-45.50%
End price
€2.42
11.05.25
Summary
This prediction ended on 11.05.25 with a price of €2.42. The SELL prediction by dimontalban for Cardiff Oncology Inc. performed very well with a performance of -45.50%. dimontalban has 60% into this prediction
Performance without dividends (%)
Name 1w 1m
Cardiff Oncology Inc. 9.677% 9.677%
iShares Core DAX® 0.734% 1.458%
iShares Nasdaq 100 -2.686% -0.146%
iShares Nikkei 225® -2.261% -2.729%
iShares S&P 500 -1.346% 0.467%

According to dimontalban what are the pros and cons of Cardiff Oncology Inc. for the foreseeable future?

Pros
Valuable balance sheet
Capable Management
Innovative
Future proof or reliable business model
Fair valuation
Very good company culture
Some uniques
Differentiated customer and product portfolio
Sustainability is important
Top 10 in its market
Known brand
Cons
Probably not worthwhile Investment
very negative Cash Flow expected
Junk rating
Increased challenges to pay loans and raise capital
high free float
Revenue decline/stagnation expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
Very low/no dividend yield expected
Little Investments for future growth
ROE lower than 5% per year
Growths slower than the competition
High risks for its business
Very high cyclical dependencies

Comments by dimontalban for this prediction

In the thread Trovagene diskutieren
Prediction Sell
Perf. (%) -45.50%
Target price 1.000
Change
Ends at 19.12.25

Sell mit Kursziel 1,0

dimontalban 
0
Report Share
19.12.24
In the thread Trading Trovagene
Prediction Sell
Perf. (%) -45.50%
Target price 1.000
Change
Ends at 19.12.25

Sell beendet

dimontalban 
0
Report Share
11.05.25

Stopped prediction by dimontalban for Cardiff Oncology Inc.

sell
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€2.38
24.11.24
€0.000
24.11.25
-7.14%
09.12.24

Valuable balance sheet
Probably not worthwhile Investment
very negative Cash Flow expected
Junk rating
dimontalban 
24.11.24 70%
sell
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€1.77
10.06.22
€0.20
10.06.23
24.58%
26.06.22

Valuable balance sheet
Probably not worthwhile Investment
very negative Cash Flow expected
Junk rating
dimontalban 
10.06.22 70%